GlaxoSmithKline Pakistan Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, GlaxoSmithKline Pakistan stock has a consensus rating of "Strong Buy" and an average price target of Rs 500.00. The average 1-year stock price forecast is 31.57% higher than the current stock price, while the lowest is Rs 475.00 (+24.99%) and the highest is Rs 525.00 (+38.15%).

Price Target: Rs 500.00 (+31.57%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	Rs 475.00	Rs 500.00	Rs 500.00	Rs 525.00
Change	+24.99%	+31.57%	+31.57%	+38.15%

Analyst Ratings

The average analyst rating for GlaxoSmithKline Pakistan stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	2	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	3	3	3	3	3

Financial Forecast

Revenue This Year

68.81B

from 65.90B

4.42%

from 65.90B

Revenue Next Year

74.58B

from 68.81B

8.38%

from 68.81B

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	36.66B	41.84B	49.66B	61.19B	65.90B	68.81B
Revenue Growth	4.48%	14.13%	18.69%	23.21%	7.70%	4.42%
Gross Profit	9.87B	7.34B	3.42B	15.28B	24.28B	24.77B
Gross Margin	26.93%	17.53%	6.88%	24.97%	36.85%	36.00%
Operating Income	6.87B	5.07B	1.96B	10.25B	16.36B	18.75B
Net Income	5.35B	2.46B	533.95M	6.54B	10.03B	10.49B
Dividend / Share	7.00	-	-	10.00	17.00	18.56
Dividend Growth	-	-	-	-	70.00%	9.18%
No. Analysts	-	-	-	-	-	1

Financial currency is PKR.

Revenue Forecast

Revenue	2026	2027	2028
High	68.8B
Avg	68.8B
Low	68.8B

Revenue Growth

Revenue Growth	2026	2027	2028
High	4.4%
Avg	4.4%
Low	4.4%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-